Follow-up strategy of radiofrequency ablation for papillary thyroid microcarcinoma: defining a response-to-ablation system

X Li, L Yan, J Xiao, Y Li, Z Yang, M Zhang, Y Luo - European Radiology, 2024 - Springer
Objective To define a response-to-ablation system based on dynamic risk stratification
proposed by the 2015 American Thyroid Association guidelines for predicting clinical …

[HTML][HTML] Prediction of cervical lymph node metastasis in clinically node-negative T1 and T2 papillary thyroid carcinoma using supervised machine learning approach

M Popović Krneta, D Šobić Šaranović… - Journal of Clinical …, 2023 - mdpi.com
Papillary thyroid carcinoma (PTC) is generally considered an indolent cancer. However,
patients with cervical lymph node metastasis (LNM) have a higher risk of local recurrence …

ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence

A Tran, RJ Weigel, AC Beck - The American journal of surgery, 2024 - Elsevier
Background Rising incidence of papillary thyroid microcarcinomas (PTMC) has raised
concerns for overdiagnosis. Utility of the American Thyroid Association Risk Stratification …

[HTML][HTML] Factors influencing extrathyroidal extension of papillary thyroid cancer and evaluation of ultrasonography for its diagnosis: a retrospective analysis

H Wang, S Zhao, J Yao, X Yu, D Xu - Scientific Reports, 2023 - nature.com
Pathologists usually explore extrathyroidal extensions (ETEs) in thyroid cancer; however,
sonographers are often not concerned with ETEs. We investigated factors influencing ETEs …

[HTML][HTML] A critical analysis of the current TNM classification for differentiated thyroid carcinoma in young patients: Time for a change?

W Wang, N Bai, X Li - Frontiers in Endocrinology, 2022 - frontiersin.org
Background The current TNM classification that simply classifies differentiated thyroid
carcinoma (DTC) patients younger than 55 years into stage I and stage II based on the …

[HTML][HTML] Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and …

A Marongiu, S Nuvoli, A De Vito, S Vargiu, A Spanu… - Biomedicines, 2024 - mdpi.com
Minimal extrathyroid extension (mETE) effect on papillary thyroid carcinoma (PC) prognosis
is still debated even more so now that this factor has been removed in the 8th AJCC Edition …

Development of a risk predictive model for evaluating immune infiltration status in invasive thyroid carcinoma

R Pang, C Qin - Evidence‐Based Complementary and …, 2022 - Wiley Online Library
Aims. This study aimed to reveal the molecular characteristics and potential biomarker of
immune‐activated and immunosuppressive invasive thyroid carcinoma. Methods …

[HTML][HTML] Course and predictors of excellent response to therapy in patients with differentiated thyroid cancer at long-term follow-up

SA Samargandy, GN Qorban, AK Aljadani… - Saudi Medical …, 2024 - ncbi.nlm.nih.gov
Objectives: To investigate the long-term outcomes of differentiated thyroid cancer (DTC) and
the predictive factors for excellent and incomplete responses to therapy on long-term follow …

[PDF][PDF] Microscopic extrathyroidal extension does not affect the prognosis of patients with papillary thyroid carcinoma: A propensity score matching analysis

K Jiang, D Zhou, D Luo - Heliyon, 2024 - cell.com
Background Extrathyroidal extension (ETE) in papillary thyroid carcinoma (PTC) can be
divided into two categories based on different degrees of invasion: microscopic ETE (micro …

[HTML][HTML] Prognostic Impact of Microscopic Extra-Thyroidal Extension (mETE) on Disease Free Survival in Patients with Papillary Thyroid Carcinoma (PTC)

N Bouzehouane, P Roy, M Decaussin-Petrucci… - Cancers, 2022 - mdpi.com
Simple Summary Microscopic extra-thyroidal extension (mETE) in papillary thyroid
carcinoma (PTC) has shown no effect on survival but controversy remains regarding its …